Cost of patient follow-up after potentially curative lung cancer treatment

The two objectives of this study were to determine the range of recommended follow-up strategies for patients with lung cancer treated with curative intent and to estimate the cost of such follow-up, Ten articles delineating eight specific follow-up strategies were identified from a Medline search of the literature for 1980 through 1995, An economic analysis was done of the costs associated with the identified strategies, Charge data obtained from the Part B Medicare Annual Data file and the Hospital Outpatient Bill file were used as a proxy for cost, Follow-up intensity varied widely across strategies for 5 years of posttreatment follow-up. Medicare-allowed charges for 5-year follow-up ranged from a low of $946 to a high of $5645, When Medicare-allowed charges were converted to a proxy for actual charges by a conversion ratio of 1.62, the range was $1533 to $9145, a fivefold difference in charges, There was no indication that more intensive, higher-cost strategies increased survival or quality of life, The published literature, including textbooks, holds few answers in this area.